Is Metronidazole (Flagyl) Safe in Pregnancy?
Metronidazole is contraindicated during the first trimester of pregnancy, but after the first trimester it is safe and recommended for treating trichomoniasis and bacterial vaginosis, with no evidence of teratogenicity or adverse fetal outcomes. 1
First Trimester: Contraindicated
Do not use metronidazole during the first trimester because it crosses the placental barrier rapidly and its effects on fetal organogenesis are not fully known. 1
For bacterial vaginosis in the first trimester, use clindamycin vaginal cream 2% (one full applicator intravaginally at bedtime for 7 days) as the sole first-line treatment. 2
For trichomoniasis in the first trimester, defer treatment until the second trimester begins, even if the patient is symptomatic. 1
The rationale for treating bacterial vaginosis even in the first trimester (with clindamycin, not metronidazole) is that BV is associated with serious adverse pregnancy outcomes including premature rupture of membranes, preterm labor, and preterm birth. 2
Second and Third Trimesters: Safe and Recommended
For Trichomoniasis:
The CDC recommends metronidazole 2 g orally as a single dose for pregnant women after the first trimester. 1
The single-dose regimen is specifically chosen to minimize total fetal drug exposure while maintaining efficacy. 1
Treatment after the first trimester is warranted because trichomoniasis is associated with premature rupture of membranes and preterm delivery. 1
For Bacterial Vaginosis:
Metronidazole 250 mg orally three times daily for 7 days is the preferred systemic therapy for bacterial vaginosis in the second and third trimesters. 2
Alternative regimens include metronidazole 2 g orally as a single dose, though the 7-day course is generally preferred. 2
Meta-analyses have shown no association between metronidazole exposure during later trimesters and preterm birth, low birth weight, or congenital anomalies. 2
Evidence Supporting Safety After First Trimester
The FDA classifies metronidazole as pregnancy category B, indicating no evidence of harm to the fetus in animal studies. 2
Multiple meta-analyses and literature reviews spanning nearly four decades confirm that metronidazole is not teratogenic in humans, regardless of trimester. 3
Recent meta-analyses do not confirm historical concerns about teratogenicity, mutagenic effects, or adverse neonatal outcomes when metronidazole is used in the second and third trimesters. 2
Critical Management Points
Partner Treatment:
All sexual partners must be treated simultaneously with the same metronidazole regimen, regardless of symptoms, as untreated partners are the leading cause of treatment failure and reinfection. 1
Most infected men with trichomoniasis are asymptomatic carriers, making partner treatment essential even without confirmed testing. 1
Alcohol Avoidance:
- Patients must avoid all alcohol during metronidazole treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions. 1
Sexual Abstinence:
- Patients should abstain from sexual intercourse until both partners complete treatment and are asymptomatic. 1
Common Pitfalls to Avoid
Do not use metronidazole gel intravaginally for trichomoniasis or during the first trimester for bacterial vaginosis—topical formulations achieve inadequate cure rates (<50% for trichomoniasis) and are not supported by evidence during pregnancy. 1, 2
Do not use clindamycin vaginal cream in the second or third trimester—three trials reported increased adverse events including prematurity and neonatal infections when used later in pregnancy. 2
Do not delay treatment after the first trimester based on outdated teratogenicity concerns—the evidence clearly supports safety and the infections themselves pose greater risks to pregnancy outcomes. 1, 2
Do not omit partner treatment—failure to treat partners is the most common cause of treatment failure. 1